• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Hologic, Inc.

NASDAQ:HOLX

$16.92 -$0.05 (-0.29%)

REAL-TIME: Last trade at

Gen-Probe Remains Neutral - Analyst Blog

Earnings Scorecard: Hologic - Analyst Blog

Qiagen Expands Its Points of Need - Analyst Blog

Gen-Probe's EPS and Sales Beat - Analyst Blog

Thermo Fisher To Buy Doe & Ingalls For $175 Million Cash

Stock Upgrades And Downgrades

HOLX / GPRO Deal Could Be Good for CUR - Analyst Blog

Hologic Incurs Loss, Eyes Gen-Probe - Analyst Blog

US STOCK FUTURES: HOT STOCKS TO WATCH

Monday’s biggest gaining and declining stocks

Pre-Market Most Active for Apr 30, 2012 : BKS, QQQ, BAC, SUN, GPRO, WCRX, SIRI, BUD, HOLX, MT, MDRX

Why Gen-Probe Shares Soared

Hologic Hits Estimates in Solid Quarter

PowerShares QQQ and Gen-Probe Incorporated Among Most Active Stocks in Pre-Market Today on the Nasda

FDA Approves Conceptus' Essure Data - Analyst Blog

Don't Get Too Worked Up Over Hologic's Earnings

QGEN to Gain from Cancer Guideline - Analyst Blog

Hologic to Exchange Notes - Analyst Blog

Disappointing 4Q for Conceptus - Analyst Blog

How Does Boston Scientific Boost its Returns?

1 Reason Hologic May Be Headed for a Slowdown

4-Star Stocks Poised to Pop: Hologic

Something Worth Watching at Hologic

Earnings Scorecard: Hologic - Analyst Blog

1 Reason Hologic Looks Weak

Hologic Outruns Estimates Again

Hologic Tops Estimates - Analyst Blog

Opening View: Futures are Down Amid Ongoing Greece Stability Concerns

Does Boston Scientific Pass Buffett's Test?

Several Setbacks for Conceptus - Analyst Blog

A No-Good, Really Bad, Awful Year for This Pharmaceutical Company

Here's How Varian Medical Systems Is Making You So Much Cash

FDA Nod for Hologic's Cervista HTA - Analyst Blog

Cepheid Stays Neutral - Analyst Blog

1 Reason Gen-Probe's Earnings Aren't So Hot

Conceptus Lowers 2011 Guidance - Analyst Blog

Gen-Probe Passes This Key Test

Here's How Hologic Is Making You So Much Cash

IsoRay Begins GliaSite Shipment - Analyst Blog

1 Reason Hologic May Be Headed for a Slowdown

See More Articles...